LYMPHADENOPATHY

Clinical trials for LYMPHADENOPATHY explained in plain language.

Never miss a new study

Get alerted when new LYMPHADENOPATHY trials appear

Sign up with your email to follow new studies for LYMPHADENOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

Promising antibody therapy targets rare protein disorder

Disease control Completed

This study tested a drug called isatuximab in 43 people with AL amyloidosis, a rare disease where abnormal proteins build up in organs. The drug is a lab-made antibody that helps the immune system attack the faulty cells making these proteins. The goal was to see if it could lowe…

Matched conditions: LYMPHADENOPATHY

Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control

Last updated May 19, 2026 12:00 UTC

LYMPHADENOPATHY

Get alerted when new LYMPHADENOPATHY trials appear

Promising antibody therapy targets rare protein disorder